Equilibration method for high resolution imaging of lung compliance and distribution of functional residual capacity

• US 7,072,706 B2
• Filed: 02/08/2002
• Issued: 07/04/2006
• Est. Priority Date: 02/08/2001
• Status: Active Grant

• Current Assignee: Trustees Of The University Of Pennsylvania (University of Pennsylvania)
• Original Assignee: Trustees Of The University Of Pennsylvania (University of Pennsylvania)
• Inventors: Lipson, David, Roberts, David, Rizi, Rahim, Baumgardner, James, Schnall, Mitchell
• Primary Examiner(s): Smith, Ruth S.
• Application Number:
  US10/071,435
• Publication Number:
  US 20030023162A1
• Time in Patent Office: 1,607 Days
• Field of Search: 600/410, 600/420, 600/529, 600/533, 600/538
• US Class Current: 600/420
• CPC Class Codes: A61B 5/055 involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
• CPC Class Codes: G01R 33/5601 involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent

Abstract

The present invention offers novel equilibration methods for very high resolution, three-dimensional imaging of imaging of lung compliance and distribution of functional residual capacity (FRC) in the lung using hyperpolarized helium-3 (³He) gas (H³He), and collecting local magnetic resonance image data therefrom. Using the present methods permits many functions that have been performed on a regional level for the whole lung using non-polarized helium, to be calculated for the first time from the local MRI measurements of local H³He, such as measuring volume or compliance.

Claims

1. An equilibration method for very high resolution, three-dimensional imaging and determination of pulmonary compliance, wherein the method comprises:

delivering and distributing a predetermined volume of hyperpolarized noble gas to conducting airways in each ventilated lung region of a pulmonary system, wherein the lung is inflated and sealed, or during a lung-inflating held breath (tidal volume);

measuring distributed volume of local concentrations of the hyperpolarized noble gas in the airways by high resolution, three-dimensional local magnetic resonance imaging, wherein the lung image is segmented using scale-based fuzzy connectedness; and

calculating local pulmonary compliance from said imaged distribution.

2. The method of claim 1, wherein the noble gas is hyperpolarized helium-3 gas (H³He).

3. The method of claim 2, further comprising dividing the lung images into as many distinct voxels as imaging resolution permits.

4. The method of claim 3, further comprising calculating local lung volume by dividing average signal intensity in each voxel by tracheal signal intensity.

5. The method of claim 4, further comprising calculating average concentration of H³He in each voxel by dividing an amount of H³He in each voxel by volume of the voxel, and calculating amount of H³He in each voxel by multiplying concentration of H³He in the gas space of the voxel by volume of gas space in the voxel.

6. The method of claim 5, further comprising calculating compliance of the voxel by calculating pressure difference between alveolar gas inside the voxel and pleural space outside of the lung, and calculating local compliance in the voxel by dividing the volume of the voxel by transmural pressure gradient (tracheal minus esophageal pressures).

7. An equilibration method for very high resolution, three-dimensional imaging and determination of lung functional residual capacity (FRC) using hyperpolarized noble gas, wherein the method comprises:

delivering and distributing a predetermined volume of hyperpolarized noble gas to conducting airways in each ventilated lung region of a pulmonary system;

measuring distributed volume of local concentrations of the hyperpolarized noble gas to provide local FRC by high resolution, three-dimensional local magnetic resonance imaging, wherein the lung image is segmented using scale-based fuzzy connectedness; and

determining whole lung FRC based upon summation of the local FRC measurements.

8. The method of claim 7, wherein the noble gas is hyperpolarized helium-3 gas (H³He).

9. The method of claim 8, further comprising dividing the lung images into as many distinct voxels as imaging resolution permits.

10. The method of claim 9, further comprising, calculating local lung volume by dividing average signal intensity in each voxel by tracheal signal intensity.

11. The method of claim 10, further comprising calculating average concentration of H³He in each voxel by dividing an amount of H³He in each voxel by volume of the voxel, and calculating amount of H³He in each voxel by multiplying concentration of H³He in the gas space of the voxel by volume of gas space in the voxel.

12. The method of claim 11, further comprising calculating local FRC by dividing signal intensity in the voxel by tracheal signal intensity, and then multiplying by volume of the voxel.

13. The method of claim 12, further comprising summing all local FRC from each voxel to determine whole lung FRC.

14. An equilibration method for very high resolution, three-dimensional imaging and determination of pulmonary compliance and distribution of lung functional residual capacity (FRC) using hyperpolarized noble gas, wherein the method comprises:

delivering and distributing a predetermined volume of hyperpolarized noble gas to conducting airways in each ventilated region of a pulmonary system, wherein the lung is inflated and sealed, or during a lung-inflating held breath (tidal volume);

measuring distributed volume of local concentrations of the hyperpolarized noble gas in the airways by high resolution, three-dimensional local magnetic resonance imaging and local FRC, wherein the lung image is segmented using scale-based fuzzy connectedness;

calculating local pulmonary compliance from said measured distribution; and

determining whole lung FRC based upon summation of the local FRC measurements.

15. The method of claim 14, wherein the noble gas is hyperpolarized helium-3 gas (H³He).

16. The method of claim 15, further comprising dividing the lung images into as many distinct voxels as imaging resolution permits.

17. The method of claim 16, further comprising calculating local lung volume by dividing average signal intensity in each voxel by tracheal signal intensity.

18. The method of claim 17, further comprising calculating average concentration of H³He in each voxel by dividing an amount of H³He in each voxel by volume of the voxel, and calculating amount of H³He in each voxel by multiplying concentration of H³He in the gas space of the voxel by volume of gas space in the voxel.

19. The method of claim 18, further comprising calculating local FRC by dividing signal intensity in the voxel by tracheal signal intensity, and then multiplying by volume of the voxel.

20. The method of claim 19, further comprising calculating compliance of the voxel by calculating pressure difference between alveolar gas inside the voxel and pleural space outside of the lung, and calculating local compliance in the voxel by dividing the volume of the voxel by transmural pressure gradient (tracheal minus esophageal pressures).

21. The method of claim 15, wherein the method for very high resolution, three-dimensional imaging of pulmonary compliance and distribution of functional residual capacity (FRC) in the lung using H³He is applied to the pulmonary system of a mammalian subject.

22. The method of claim 21, wherein the mammalian subject is human.

23. The method of claim 21, wherein the lung is normal.

24. The method of claim 21, wherein the lung is injured or diseased.